Clinical Trials

• Y402H Comlement Factor H Polymorphism and Age-Related Macular Degeneration in the Austrian Population
  ClinicalTrials.gov Identifier: NCT00533754 - Active, not recruiting
  Age-Related Macular Degeneration
  
• YAG Laser Versus Punch Biopsy for the Treatment of Tattoo Skin Markers
  ClinicalTrials.gov Identifier: NCT00271674 - Recruiting
  Tattoo Skin Markers
  
• Yakima Head Start Fluoride Varnish Study
  ClinicalTrials.gov Identifier: NCT00067353 - Active, not recruiting
  Dental Caries
  
• Yaz SH T00186D in a Flexible Extended Regimen
  ClinicalTrials.gov Identifier: NCT00567164 - Recruiting
  Healthy
  
• Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030.
  ClinicalTrials.gov Identifier: NCT00329745 - Active, not recruiting
  Rotavirus Gastroenteritis
  
• Yellow Fever Virus Vaccine and Immune Globulin Study
  ClinicalTrials.gov Identifier: NCT00254826 - Recruiting
  Viremia; Yellow Fever Virus Vaccine
  
• YM443 in Subjects with Functional Dyspepsia
  ClinicalTrials.gov Identifier: NCT00102310 - Completed
  Indigestion; Nausea
  
• YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00048659 - Terminated
  Hormone-Refractory Prostate Cancer; Prostatic Neoplasms
  
• YM598 in patients with rising PSA after initial therapy for localized prostate cancer
  ClinicalTrials.gov Identifier: NCT00050297 - Terminated
  Prostate Cancer
  
• Yoga and Inflammatory Arthritis
  ClinicalTrials.gov Identifier: NCT00349869 - Recruiting
  Inflammatory Arthritis; Osteoarthritis
  
• Yoga as a Therapy for Traumatic Experiences
  ClinicalTrials.gov Identifier: NCT00269490 - Completed
  Post-Traumatic Stress Disorder
  
• Yoga as a Treatment for Insomnia
  ClinicalTrials.gov Identifier: NCT00033865 - Recruiting
  Insomnia
  
• Yoga Breath Program and Client-Centered Exposure for Relief of PTSD in Tsunami Victims
  ClinicalTrials.gov Identifier: NCT00290225 - Completed
  Posttraumatic Stress Disorder; Depression
  
• Yoga for Breast Cancer Survivors: Effects on Fatigue, Immune Function, and Mood
  ClinicalTrials.gov Identifier: NCT00486525 - Recruiting
  Breast Cancer
  
• Yoga for Patients With Epilepsy
  ClinicalTrials.gov Identifier: NCT00179452 - Recruiting
  Epilepsy
  
• Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
  ClinicalTrials.gov Identifier: NCT00090506 - Active, not recruiting
  HIV Infections; Diabetes; Depression
  
• Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00051792 - Completed
  Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive; Pulmonary Emphysema; Chronic Bronchitis
  
• Yoga for Treatment of Hot Flashes
  ClinicalTrials.gov Identifier: NCT00283205 - Completed
  Menopause-Related Hot Flashes
  
• Yoga for Women Attempting Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00492310 - Not yet recruiting
  Smoking
  
• Yoga in Controlling Symptoms and Reducing Stress in Women With Ovarian Cancer or Breast Cancer
  ClinicalTrials.gov Identifier: NCT00337233 - Active, not recruiting
  Breast Cancer; Fatigue; Ovarian Cancer; Psychosocial Effects/Treatment
  
• Yoga in Treating Sleep Disturbance in Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00397930 - Recruiting
  Depression; Fatigue; Sleep Disorders; Unspecified Adult Solid Tumor, Protocol Specific
  
• Yoga Study in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00476203 - Recruiting
  Breast Cancer
  
• Yoga to Reduce Cancer Fatigue
  ClinicalTrials.gov Identifier: NCT00583739 - Recruiting
  Breast Neoplasm
  
• Yoga, Immune Function, and Health
  ClinicalTrials.gov Identifier: NCT00371397 - Recruiting
  Immune Function
  
• Yoga-Based Cancer Rehabilitation Program
  ClinicalTrials.gov Identifier: NCT00179348 - Recruiting
  Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms
  
• Yoga: Effect on Attention in Aging & Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00010998 - Completed
  Multiple Sclerosis
  
• Yohimbine to Induce Rapid Antidepressant Effects
  ClinicalTrials.gov Identifier: NCT00078715 - Recruiting
  Depression, Involutional
  
• Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
  ClinicalTrials.gov Identifier: NCT00549926 - Recruiting
  Coronary Disease; Hypercholesterolemia
  
• Young Adult Influenza Vaccine Immunogenicity Substudy
  ClinicalTrials.gov Identifier: NCT00170508 - Active, not recruiting
  Influenza
  
• Young Driver Intervention Study
  ClinicalTrials.gov Identifier: NCT00062829 - Active, not recruiting
  Accidents, Traffic; Health Education
  
• Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
  ClinicalTrials.gov Identifier: NCT00525460 - Recruiting
  Ovarian Cancer
  
• Young Women's Breast Cancer Research Program
  ClinicalTrials.gov Identifier: NCT00276120 - Recruiting
  Invasive Breast Cancer
  
• Youth Drug Abuse Family and Cognitive-Behavioral Therapy
  ClinicalTrials.gov Identifier: NCT00198874 - Recruiting
  Drug Abuse
  
• Youth Empowerment Solutions for Peaceful Communities
  ClinicalTrials.gov Identifier: NCT00164593 - Recruiting
  Violence; Juvenile Delinquency; Social Problems; Social Control, Informal
  
• Youth-Nominated Support Team Intervention for Suicidal Adolescents
  ClinicalTrials.gov Identifier: NCT00071617 - Completed
  Mental Disorders
  
• YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00450398 - Active, not recruiting
  Liver Diseases
  
• YSPSL for Prevention of Delayed Graft Function Part A
  ClinicalTrials.gov Identifier: NCT00298181 - Active, not recruiting
  Delayed Graft Function
  
• YSPSL for Prevention of Delayed Graft Function Part B
  ClinicalTrials.gov Identifier: NCT00298168 - Active, not recruiting
  Kidney Diseases
  
• Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00386321 - Recruiting
  Diffuse Large B-Cell Lymphoma
  
• Yttrium Y 90 DOTA Monoclonal Antibody HuPAM4 in Treating Patients With Stage III or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00303680 - Recruiting
  Pancreatic Cancer
  
• Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00062114 - Completed
  recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult immunoblastic large cell lymphoma
  
• Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder
  ClinicalTrials.gov Identifier: NCT00064246 - Completed
  adult Burkitt's lymphoma; adult diffuse large cell lymphoma; indolent, adult non-Hodgkin's lymphoma; post-transplant lymphoproliferative disorder
  
• Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
  ClinicalTrials.gov Identifier: NCT00453102 - Recruiting
  Lymphoma
  
• Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00073957 - Recruiting
  recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
  
• Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
  ClinicalTrials.gov Identifier: NCT00060294 - Completed
  Waldenstrom's Macroglobulinemia
  
• Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00562978 - Active, not recruiting
  Lymphoma
  
• Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, and Radiation Therapy in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Relapsed Or Refractory Non-Hodgkin''s Lymphoma
  ClinicalTrials.gov Identifier: NCT00119392 - Recruiting
  adult non-Hodgkin''s lymphoma
  
• Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00577278 - Recruiting
  Graft Versus Host Disease; Leukemia; Lymphoma
  
• Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
  ClinicalTrials.gov Identifier: NCT00006368 - Active, not recruiting
  Lung Cancer; Melanoma; Lymphoma; Brain Tumor; Breast Cancer
  
• Yttrium-90 Ibritumomab Tiuxetan (Zevalin) with BEAM in Relapsed Low Grade B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00138086 - Completed
  B Cell Lymphoma